SuperworthTenax Therapeutics shares outstanding TENX
Diluted shares outstanding, averaged over each quarter, from 2010.
- Latest quarter, to Jun 30, 2026
- 50.9M
- On a year earlier
- +28.5%
- more shares
Tenax Therapeutics had 50.9M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 28.5% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 40.9M | +13% |
| FY2024 | 36.1M | +11999% |
| FY2023 | 298.3K | +1069% |
| FY2022 | 25.5K | +62% |
| FY2021 | 15.8K | +274% |
| FY2019 | 4.2K | +252% |
| FY2018 | 1.2K | +36% |
| FY2017 | 882 | +0% |
| FY2016 | 879 | +0% |
| FY2015 | 879 | +38% |
| FY2014 | 636 | +948% |
| FY2013 | 61 | +24% |
| FY2012 | 49 | +33% |
| FY2011 | 37 | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 50.9M | +29% | |
| Q1 FY26 | 45.2M | +24% | |
| Q4 FY25 | 40.9M | +13% | |
| Q3 FY25 | 39.7M | +88% | |
| Q2 FY25 | 39.6M | +1921% | |
| Q1 FY25 | 36.6M | +2901% | |
| Q4 FY24 | 36.1M | +11999% | |
| Q3 FY24 | 21.2M | +6994% | |
| Q2 FY24 | 2M | +608% | |
| Q1 FY24 | 1.2M | +949% | |
| Q4 FY23 | 298.3K | +1069% | |
| Q3 FY23 | 298.3K | +1713% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Tenax Therapeutics
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.